Salmonella lipopolysaccharide O-antigen (LPS O-antigen)

Salmonella lipopolysaccharide (LPS) O-antigen is the distal, surface-exposed polysaccharide component of the LPS complex found in the outer membrane of Gram-negative Salmonella bacteria (PubMed: 26331770). It consists of repeating oligosaccharide units that exhibit significant structural diversity, serving as the primary basis for the Kauffman-White serotyping scheme used to identify thousands of Salmonella serovars (NCBI: NBK8435). Biologically, the O-antigen acts as a critical virulence factor by shielding the bacterium from host immune mechanisms, such as the membrane attack complex of the complement system and phagocytic uptake (PubMed: 11544343). It also plays a role in bacterial adhesion and colonization of host tissues. In medicine, the O-antigen is a major target for the development of glycoconjugate vaccines, particularly against non-typhoidal Salmonella (NTS) and Salmonella Paratyphi, for which no widely available vaccines exist (PubMed: 29136439). These vaccines aim to induce high-titer, serotype-specific antibodies that promote opsonophagocytosis and bacterial clearance. Therapeutic challenges include the high degree of antigenic variation between serotypes and the potential for endotoxicity if the Lipid A moiety is not properly managed during vaccine formulation.

Other names

O-polysaccharideO-side chainSalmonella O-antigenO-specific chainO-antigenic determinant

Induction of opsonophagocytic antibodies through active immunization; binding and neutralization of bacterial surface antigens to prevent host cell attachment; disruption of outer membrane integrity via binding to the lipopolysaccharide complex.